BSNM Annual Meeting

The British Society for Nanomedicine (BSNM) are pleased to announce this year’s Annual Meeting. This event builds on the successes of our previous meetings and will take place on the 22nd & 23rdAugust 2022. It will provide an excellent opportunity for researchers to showcase innovative research and discuss outputs and opportunities with both senior and young researchers and experts within the field of nanomedicine.

  • The BSNM Annual Meeting is opportunity to give a short talk and present an overview of your work and your research findings (Max 15mins)
  • REGISTRATION DEADLINE EXTENDED: Friday 12th August!! To register, please follow the link here

BSNM Annual Meeting 2022: Programme

Day 1: Monday 22nd August

10:00 – 10:50 Registration and coffee

Session 1: Nanoparticles for Cancer Therapy

10:45 – 10:55 Welcome and event introduction
10.55 – 11:15 SESSION LEAD: Dr Lewis Francis (Swansea University) – Precision medicine technology informed future therapies for ovarian cancer
11:15 – 11:30 Khadeejah Maeyouf (Strathclyde University) – Synthesis, characterization and in vitro evaluation of a novel tumour-targeted zein-based delivery system for prostate cancer therapy
11:30 – 11:45 Ubah Abdi (Queens’s University Belfast) – Targeting the pancreatic tumour microenvironment using B7-H3 targeted vismodegib-poly(lactic-co-glycolic) acid nanoparticles
11:45 – 12:00 Robert Cavanagh (University of Nottingham) – Prodrug nanoparticle loaded supramolecular hydrogels for drug delivery to glioblastoma

12:00 – 12:30 Coffee break

Session 2: Nano-Biological Interactions I

12:30 – 12:50 SESSION LEAD: Professor Arwyn Jones (Cardiff University) – Endocytic Profiling for Analysing the Cellular Uptake, Intracellular Trafficking and Delivery Capacity of Nanomedicines
12:50 – 13:05 Joe Fox (University of Leeds) – Synthesis of Novel Gold Nanoparticle Morphologies for Applications in a Cancer Biomarker Lateral Flow Assay
13:05 – 13:20 Rafal Baker (King’s College London) – Nose-to-brain Delivery of Riluzole-loaded Polymeric Nanoparticles for The Treatment of Amyotrophic Lateral Sclerosis
13:20 – 13:35 Rahul Shukla (National Institute of Pharmaceutical Education and Research) – Development and evaluation of Silibinin loaded Glyceryl monooleate Nano liquid crystalline for Alzheimer’s therapy.

13:35 – 15:00 Late Lunch and poster session 1

Session 3: Nano-Biological Interactions II

15:00 – 15:20 SESSION LEAD: Dr Paul Hole (ReNeuron) – Extracellular vesicles: Delivering on the promises of next-gen therapeutics
15:20 – 15:35 Kirsty Meldrum (Swansea University) – An in vitro approach towards elucidating the safety of nanomaterials
15:35 – 15:50 Medina Guliyeva (University College London) – The role of Apolipoproteins in protein corona formation and cellular uptake of gold nanoparticles
15:50 – 16:05 Sarwar Beg (University of Central Lancashire) – Co-delivery of temozolomide and γ-linolenic acid via nanostructured lipid carriers for treatment of glioblastoma multiforme

16:05 – 17:30 Coffee break

Session 4: Novel Nanomaterials

17:30 – 17:50 SESSION LEAD: Dr Elaine Ferguson (Cardiff University) – Dextrin-colistin conjugates designed to ameliorate acute kidney injury
17:50 – 18:05 Kadie Edwards (Swansea University) – Advanced in vitro selection processes define drug delivery strategies in solid tumour cancers
18:05 – 18:20 Pratik Gurnani (University of Nottingham) – Self-amplifying RNA delivery using charge reversal polymers
18:20 – 18:35 Weiqi Zhang (King’s College London) – Characterising chemical and physical properties of phase-change nanodroplets.

18:35 – 21.00 Dinner and Drinks Reception (including networking event)

21:00 – Late Follow up social event for those that are up for it!

Day 2: Tuesday 23rd August

9:00 – 10:00 BSNM AGM

Session 5: Nanoparticles for Drug Delivery

10:00 – 10:20 SESSION LEAD: Professor Andrew Owen (University of Liverpool) – Long-acting drug delivery for anti-infective agents
10:20 – 10:35 Hawraa Ali-Jerman (Strathclyde Uni) – Design of stealth nanoparticles for DNA delivery to cancer cells
10:35 – 10:50 Nurcan Gumus (University of Nottingham) – siRNA therapeutic agent delivery via synthetic polycations in glioblastoma

10:50 – 11:30 Coffee break

Session 6: Nanoparticle Fabrication

11:30 – 11:50 SESSION LEAD: Beth Hinchliffe (National Physical Laboratory) – Deagglomeration of DNA nanomedicine carriers using controlled ultrasonication
11:50 – 12:05 Naveed Ahmad (King’s College London) – Exploiting design of experiment for the development of polymeric nanoparticles for intranasal delivery of oxytocin to treat neurodevelopmental disorders
12:05 – 12:20 Chantelle Spiteri (Kings College London) – mRNA delivery by laser-induced poration using porous silicon nanoparticles
12:20 – 12:35 Cameron Hogarth (University of Liverpool) – Evaluating the impact of systematic hydrophobic modification of model drugs on the control, stability and loading of lipid-based nanoparticles

12:35 – 14:00 Lunch and poster session 2

Session 7: Innovative Microbial Applications for Nanomaterials

14:00 – 14:20 SESSION LEAD: Professor Kamalinder Singh (University of Central Lancashire) – Targeted lung delivery of antifungal drug with nebulised surface-active hybrid nanoparticles for treatment of pulmonary aspergillosis
14:20 – 14:35 Ioanna Mela (University of Cambridge) – DNA nanostructures as a tool for targeted antimicrobial delivery
14:35 – 14:50 Gebremariam Birhanu Wondie (University of the Free State) – Green synthesized zinc oxide nanoparticles for ciprofloxacin delivery against UTI resistant bacteria

14:50 – 15:45 Informal discussion groups with coffee: Nano-characterisation and toxicology

15:45 – 16:00 Discussion group feedback and poster removal

16:00 – 16:30 Prize giving and closing ceremony. Meeting closed.